Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Compare common budgeting styles against your income and goals to determine the best fit. A practical guide to choosing effectively.
24,732 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Beef prices are climbing, and Texas barbecue joints are adjusting menus, portions, and protein options to weather the...
Palo Alto Networks fell sharply after reporting a solid Q2 on earnings but guiding Q3 profits below expectations. The...
Bitcoin climbs toward $72,000 as spot ETF inflows continue into a second session, despite rising geopolitical risk in...
A margin increase on COMEX silver futures unleashed a swift selloff, sending prices skidding and testing key support....
Zcash (ZEC) surged about 40% in a single session, reclaiming a spot among crypto's top names as privacy-focused coins...
Analysts weigh the implications of a hypothetical kevin warsh sworn federal chair scenario. Markets could reprice pol...
Institutional holders control roughly 87% of Starbucks' float, and analysts expect further upside as comps improve an...
Markets surge as investors debate mega-valuations tied to founder-led tech giants. This piece breaks down what everyd...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
Bitcoin faces renewed volatility as veteran trader Peter Brandt hints at moving BTC into gold, sparking a fresh debat...
Founders Fund has fully exited ETHZilla, and Peter Thiel has followed with a complete stake unload, underscoring a br...